Collaboration is not a single project. It’s an operating model.
From good intentions to operational collaboration.
94% of SCRS Global Impact Partners report collaborating with another organization to address a common challenge or improve their business.
Download the Collaborate Forward Playbook to explore practical examples and tools that your organization can implement to improve study performance.
What You’ll Learn
This playbook introduces four pillars that help organizations operationalize collaboration:
Executive Leadership Support
Making site-centric collaboration a visible strategic priority
Operational Impact of Collaboration
Designing processes that reduce friction and accelerate timelines
Information Governance
Creating shared data, metrics, and transparency across partners.
Ongoing Feedback Loops
Capturing and acting on feedback from sites and stakeholders.
SCRS Collaborate Forward InterVIEWS
Listening First, Following Through: How Scout Responds to Site Realities and Feedback
For sites, the reality of clinical research is defined by operations—how logistics, payments, travel, and participant support actually work in practice. When this layer works well, studies move forward with fewer disruptions. When it
Bridge the Technology Gaps: How Advarra Strengthens Site–Sponsor Collaboration
Understanding Today’s Collaboration Challenges One of the biggest barriers to effective study collaboration is the disconnect in how sponsors, CROs, and sites think about technology. According to Ashley Davidson, VP and Product Lead for
Elevating the Site Voice through Action, Accountability, and Design
Medidata’s Site Insights Program reflects a deliberate shift toward transparency, efficiency, and true site-centricity in clinical research. Built on the belief that better technology starts with better listening, the program embeds the site voice
Strengthening Site Partnerships: Through Trust, Transparency, and Tailored Solutions
Merck’s approach to site partnerships has evolved in response to two key drivers: the growing complexity of clinical trials and the need to foster meaningful, sustainable collaborations with sites. What began as a traditional